Review
doi: 10.1038/nrd746.
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Affiliations
- PMID: 12120504
- DOI: 10.1038/nrd746
Item in Clipboard
Review
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Nat Rev Drug Discov.
2002 Mar.
Abstract
Cell-surface receptors are the targets for more than 60% of current drugs. Traditionally, optimizing the interaction of lead molecules with the binding site for the endogenous agonist (orthosteric site) has been viewed as the best means of achieving selectivity of action. However, recent developments have highlighted the fact that drugs can interact with binding sites on the receptor molecule that are distinct from the orthosteric site, known as allosteric sites. Allosteric modulators could offer several advantages over orthosteric ligands, including greater selectivity and saturability of their effect.
Similar articles
-
Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.Neuropharmacology. 2011 Jan;60(1):24-35. doi: 10.1016/j.neuropharm.2010.07.010. Epub 2010 Jul 15. Neuropharmacology. 2011. PMID: 20637785 Review.
-
G-protein-coupled receptor allosterism: the promise and the problem(s).Biochem Soc Trans. 2004 Nov;32(Pt 5):873-7. doi: 10.1042/BST0320873. Biochem Soc Trans. 2004. PMID: 15494038 Review.
-
Identifying novel modulators of G protein-coupled receptors via interaction at allosteric sites.Curr Opin Drug Discov Devel. 2005 Sep;8(5):567-76. Curr Opin Drug Discov Devel. 2005. PMID: 16159018 Review.
-
Screening for positive allosteric modulators of biological targets.Drug Discov Today. 2006 Jul;11(13-14):632-9. doi: 10.1016/j.drudis.2006.05.010. Drug Discov Today. 2006. PMID: 16793532 Review.
-
Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.Med Res Rev. 2010 May;30(3):463-549. doi: 10.1002/med.20166. Med Res Rev. 2010. PMID: 19557759 Review.
Cited by
-
Properties of protein drug target classes.PLoS One. 2015 Mar 30;10(3):e0117955. doi: 10.1371/journal.pone.0117955. eCollection 2015. PLoS One. 2015. PMID: 25822509 Free PMC article.
-
Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain.Acta Pharm Sin B. 2024 Jan;14(1):67-86. doi: 10.1016/j.apsb.2023.07.020. Epub 2023 Jul 21. Acta Pharm Sin B. 2024. PMID: 38239234 Free PMC article. Review.
-
Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs.Nat Commun. 2019 Jul 23;10(1):3289. doi: 10.1038/s41467-019-11062-7. Nat Commun. 2019. PMID: 31337749 Free PMC article.
-
Identification of Alternative Allosteric Sites in Glycolytic Enzymes for Potential Use as Species-Specific Drug Targets.Front Mol Biosci. 2020 May 14;7:88. doi: 10.3389/fmolb.2020.00088. eCollection 2020. Front Mol Biosci. 2020. PMID: 32478093 Free PMC article.
-
Analysis of tractable allosteric sites in G protein-coupled receptors.Sci Rep. 2019 Apr 16;9(1):6180. doi: 10.1038/s41598-019-42618-8. Sci Rep. 2019. PMID: 30992500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
